Cognixion + Apple Vision Pro for ALS
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to test a new communication system for individuals with conditions such as late-stage ALS, traumatic brain injury, or spinal cord injury who require assistance with communication. Participants will use a device that combines Cognixion technology and Apple Vision Pro, featuring an augmented reality interface and brain-computer interface (BCI) to aid communication. The trial will assess how effectively participants can use these tools and how the system can be personalized to meet their needs. Eligible participants must be able to open their eyes for at least 30 minutes and have an alternative method of communication, such as nodding or blinking. This study may suit those with communication challenges due to their condition who wish to try new technology to help express themselves. As an unphased trial, it offers a unique opportunity for participants to explore innovative technology that could significantly enhance their communication abilities.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that the Cognixion + Apple Vision Pro device is safe for use in individuals with ALS, TBI, or SCI?
Research has shown that the Cognixion + Apple Vision Pro system likely has manageable side effects for people with ALS, traumatic brain injury, or spinal cord injury. Although detailed safety data from past studies is unavailable, the device employs a non-invasive method with brainwave and eye-tracking technology, designed to reduce risks. This device uses advanced technology to enhance communication. Participants in previous studies generally performed well with similar technologies, indicating a good level of safety.12345
Why are researchers excited about this trial?
Researchers are excited about the Cognixion + Apple Vision Pro for ALS because it offers a unique approach to communication and computer control for individuals with ALS. Unlike traditional methods that rely on physical movement or speech, this device uses brain-computer interface (BCI) technology, allowing users to interact directly with their devices through brain signals. This could provide a more intuitive and accessible way for people with ALS to communicate and perform tasks, potentially enhancing their independence and quality of life. Additionally, the integration of eye-tracking BCI (ET-BCI) offers an innovative modality that combines eye movement with brain signals for even more precise control.
What evidence suggests that the Cognixion + Apple Vision Pro device is effective for communication in individuals with ALS, TBI, or SCI?
Research has shown that the Cognixion + Apple Vision Pro system might assist individuals with communication challenges due to conditions like ALS (amyotrophic lateral sclerosis), traumatic brain injury (TBI), and spinal cord injury (SCI). This system employs brainwave and eye-tracking technology to aid communication. Studies have found that these technologies can convert thoughts or eye movements into computer commands, facilitating communication. Early results indicate that the system has manageable side effects and functions effectively for people with ALS. The goal is to enhance users' control and independence by improving their ability to connect with others and their environment.12356
Who Is on the Research Team?
Christopher J Ullrich
Principal Investigator
Cognixion
Are You a Good Fit for This Trial?
This trial is for up to 10 people in the US with late-stage ALS, traumatic brain injury (TBI), or spinal cord injury (SCI) who need help communicating and using computers. Participants should be able to commit to a study duration of 3-4 months.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants utilize the Cognixion + Apple Vision Pro device for communication tasks and practice various modalities including BCI and ET-BCI
Follow-up
Participants are monitored for usability and effectiveness of the communication platform after the treatment phase
What Are the Treatments Tested in This Trial?
Interventions
- Cognixion + Apple Vision Pro
Find a Clinic Near You
Who Is Running the Clinical Trial?
Cognixion
Lead Sponsor